Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer

E-ISSN： 2212-3970|10|2|133-144

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.10, Iss.2, 2015-05, pp. : 133-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1156-1162

Spandidos Publications

Access to resources Recommend Favorite

Therapeutic management of epithelial ovarian cancer during pregnancy

By Minig L.

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 259-264

Springer Publishing Company

Access to resources Recommend Favorite

Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 861-867

Spandidos Publications

Access to resources Recommend Favorite

Splenectomy in Recurrent Epithelial Ovarian Cancer

By Gemignani M.L. Chi D.S. Gurin C.C. Curtin J.P. Barakat R.R.

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 407-410

Elsevier

Access to resources Recommend Favorite

Epithelial ovarian cancer: A case report

Experimental and Therapeutic Medicine, Vol. 8, Iss. 5, 2014-01 ,pp. : 1535-1538

Spandidos Publications

Access to resources Recommend Favorite